Back
Eton Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
71
ETON
Eton Pharmaceuticals
Last Price:
9.13
Seasonality Move:
9.82%
Buy
61
BMRN
Biomarin Pharmaceutical
Last Price:
66.13
Seasonality Move:
13.04%
Buy
71
Eton Pharmaceuticals (ETON)
is a Buy
Is Eton Pharmaceuticals a Buy, Sell or Hold?
- The current Eton Pharmaceuticals [ETON] share price is $9.74. The Score for ETON is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- ETON is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $66.36. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ETON Stock Price Chart
What is Eton Pharmaceuticals's stock price today?
-
The Eton Pharmaceuticals share price today is $9.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ETON is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $66.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
ETON Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 79.81 | Buy |
| Chaikin Money Flow: | 426974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.85 - 8.79) | Buy |
| Bollinger Bands (100): | (3.31 - 7.25) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.73 | Sell |
| Relative Strength Index (14 RSI): | 34.15 | Sell |
| Chaikin Money Flow: | -864914 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.92 - 70.46) | Sell |
| Bollinger Bands (100): | (70.6 - 88.08) | Sell |
ETON Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.72 | Buy |
| 20-day SMA: | 8.49 | Buy |
| 50-day SMA: | 6.88 | Buy |
| 200-day SMA: | 4.57 | Buy |
| 8-day EMA: | 8.84 | Buy |
| 20-day EMA: | 8.35 | Buy |
| 50-day EMA: | 7.16 | Buy |
| 200-day EMA: | 5.09 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.38 | Sell |
| 20-day SMA: | 68.48 | Sell |
| 50-day SMA: | 72.64 | Sell |
| 200-day SMA: | 82.19 | Sell |
| 8-day EMA: | 66.88 | Sell |
| 20-day EMA: | 68.21 | Sell |
| 50-day EMA: | 72.28 | Sell |
| 200-day EMA: | 80.84 | Sell |
Eton Pharmaceuticals Earnings Growth & ETON Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.71 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
Eton Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||